|
Contempory issues in management
|
|
|
THE LINK BETWEEN BONE AND CARDIOVASCULAR DISEASE: THE CENTRAL ROLE OF PHOSPHATE
|
|
|
|
|
|
|
|
|
Avoid Calcium………..
|
|
|
Optimizing the Treatment of Hyperphosphatemia in Experimental Uremia
|
|
|
Consequences of Hyperphosphatemia
on Parathyroid Function
|
|
|
|
Regulation of PTH mRNA Stability by Lanthanum Carbonate in CKD
|
|
|
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
|
|
|
Effect of PFA on Ca deposition in VSMCs
|
|
|
Effect of Lanthanum on Ca deposition in VSMCs
|
|
|
|
Calciphylaxis Responsive to Lanthanum Carbonate
|
|
|
Optimizing the Treatment of Hyperphosphatemia in CKD
|
|
|
Lanthanum carbonate reduces serum phosphate levels in CKD 3/4: Randomized multicentre trial
|
|
|
25D and 1,25D Levels Are not Affected by Lanthanum Carbonate in CKD Patients
|
|
|
Optimizing the Treatment of Hyperphosphatemia in Dialysis
|
|
|
Efficacy of Lanthanum in Patients Converting From Other Treatments
|
|
|
Lanthanum Carbonate vs Sevelamer: Differential Effects on Renal Osteodystrophy
|
|
|
|
Clinical study conducted in CKD 5 dialysis patients
|
|
|
Trial design
|
|
|
Fixed dose titration
|
|
|
Change in serum phosphate from baseline during treatment periods
|
|
|
|
|
|
MAIN REMARKS
|
|
|
|
|
|
Avoid Calcium!
|
|
|
Avoid Calcium!
|
|
|
Avoid Calcium!
|
|
|
Avoid Calcium!
|
|
|
BONE-VASCULAR AXIS: THE ROLE OF PHOSPHATE
|
|
Share this page with your colleagues and friends: